tiprankstipranks
Park Ha Biological Technology Co., Ltd. (BYAH)
NASDAQ:BYAH
US Market
BYAH
Park Ha Biological Technology
RESEARCH TOOLSreports

Park Ha Biological Technology (BYAH) Ratios

87 Followers

Park Ha Biological Technology Ratios

BYAH's free cash flow for Q4 2025 was $0.86. For the 2025 fiscal year, BYAH's free cash flow was decreased by $ and operating cash flow was $-3.45. See a summary of the company’s cash flow.
Ratios
TTM
Oct 25Oct 24Oct 23Oct 22
Liquidity Ratios
Current Ratio
 2.92 2.92 1.87 1.75 0.96
Quick Ratio
 2.88 2.88 1.82 1.67 0.92
Cash Ratio
 2.01 2.01 0.36 0.83 0.24
Solvency Ratio
 -12.39 -12.39 0.32 0.70 0.09
Operating Cash Flow Ratio
 0.05 0.05 0.63 0.10 0.61
Short-Term Operating Cash Flow Coverage
 0.82 0.82 0.00 0.00 0.00
Net Current Asset Value
$ 3.54M$ 3.54M$ 1.27M$ 923.75K$ -103.81K
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.02 0.01 0.01
Debt-to-Equity Ratio
 0.05 0.05 0.05 0.03 0.17
Debt-to-Capital Ratio
 0.04 0.04 0.04 0.03 0.15
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.49 1.49 2.05 2.24 16.76
Debt Service Coverage Ratio
 -233.19 -233.19 0.00 0.00 1.14K
Interest Coverage Ratio
 -589.00K -589.00K 0.00 0.00 1.02K
Debt to Market Cap
 0.15 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.30 0.31 0.13 <0.01 <0.01
Net Debt to EBITDA
 0.15 0.15 -0.58 -0.83 -2.49
Profitability Margins
Gross Profit Margin
90.64%94.36%91.80%87.35%73.47%
EBIT Margin
-956.45%-956.45%33.32%48.01%9.91%
EBITDA Margin
-952.12%-952.12%34.28%48.82%11.50%
Operating Profit Margin
-956.45%-956.45%33.32%48.01%10.26%
Pretax Profit Margin
-953.89%-953.89%33.31%48.05%9.90%
Net Profit Margin
-965.00%-965.00%20.09%34.65%9.97%
Continuous Operations Profit Margin
-965.00%-965.00%20.09%34.65%9.97%
Net Income Per EBT
101.17%101.17%60.32%72.11%100.68%
EBT Per EBIT
99.73%99.73%99.96%100.09%96.44%
Return on Assets (ROA)
-409.31%-409.31%15.52%37.62%7.60%
Return on Equity (ROE)
-591.00%-609.90%31.78%84.15%127.30%
Return on Capital Employed (ROCE)
-593.23%-593.23%50.92%115.52%131.11%
Return on Invested Capital (ROIC)
-578.41%-578.41%30.37%81.55%111.65%
Return on Tangible Assets
-409.77%-409.77%15.56%37.76%7.62%
Earnings Yield
-3900.06%-220.91%3.81%6.79%1.52%
Efficiency Ratios
Receivables Turnover
 1.94 1.94 2.15 3.46 1.26
Payables Turnover
 19.68 11.86 8.12 1.58 3.92
Inventory Turnover
 2.79 1.68 2.73 3.24 5.41
Fixed Asset Turnover
 7.46 7.46 13.63 34.91 30.55
Asset Turnover
 0.42 0.42 0.77 1.09 0.76
Working Capital Turnover Ratio
 0.66 1.02 2.11 5.93 -4.88
Cash Conversion Cycle
 300.42 374.23 258.65 -13.38 264.64
Days of Sales Outstanding
 188.34 188.34 170.05 105.50 290.13
Days of Inventory Outstanding
 130.63 216.65 133.58 112.52 67.51
Days of Payables Outstanding
 18.55 30.76 44.97 231.40 92.99
Operating Cycle
 318.97 404.99 303.62 218.02 357.63
Cash Flow Ratios
Operating Cash Flow Per Share
 0.14 0.15 1.83 <0.01 0.06
Free Cash Flow Per Share
 >-0.01 >-0.01 1.67 <0.01 0.05
CapEx Per Share
 0.15 0.15 0.16 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 -0.03 -0.03 0.91 0.82 0.99
Dividend Paid and CapEx Coverage Ratio
 0.97 0.97 11.22 5.58 121.30
Capital Expenditure Coverage Ratio
 0.97 0.97 11.22 5.58 121.30
Operating Cash Flow Coverage Ratio
 0.48 0.48 13.66 4.02 55.06
Operating Cash Flow to Sales Ratio
 0.03 0.03 0.40 0.05 0.75
Free Cash Flow Yield
-0.42%-0.03%6.97%0.83%11.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.03 -0.45 26.22 14.73 65.60
Price-to-Sales (P/S) Ratio
 0.28 4.37 5.27 5.10 6.54
Price-to-Book (P/B) Ratio
 0.16 2.76 8.33 12.40 83.51
Price-to-Free Cash Flow (P/FCF) Ratio
 -239.51 -3.71K 14.34 120.83 8.77
Price-to-Operating Cash Flow Ratio
 7.28 128.47 13.07 99.18 8.70
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 -0.60 0.04 -0.47
Price-to-Fair Value
 0.16 2.76 8.33 12.40 83.51
Enterprise Value Multiple
 0.12 -0.31 14.79 9.62 54.38
Enterprise Value
 -2.90M 7.42M 12.07M 11.55M 12.00M
EV to EBITDA
 0.12 -0.31 14.79 9.62 54.38
EV to Sales
 -1.15 2.94 5.07 4.70 6.25
EV to Free Cash Flow
 975.14 -2.50K 13.80 111.18 8.39
EV to Operating Cash Flow
 -33.73 86.45 12.57 91.26 8.32
Tangible Book Value Per Share
 6.70 6.77 2.86 0.04 <0.01
Shareholders’ Equity Per Share
 6.71 6.78 2.87 0.04 <0.01
Tax and Other Ratios
Effective Tax Rate
 -0.01 -0.01 0.40 0.28 >-0.01
Revenue Per Share
 4.24 4.29 4.55 0.09 0.07
Net Income Per Share
 -40.95 -41.38 0.91 0.03 <0.01
Tax Burden
 1.01 1.01 0.60 0.72 1.01
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.09 0.09 0.02 0.01 0.03
SG&A to Revenue
 10.38 10.41 0.49 0.20 0.37
Stock-Based Compensation to Revenue
 3.95 0.00 0.00 0.00 0.00
Income Quality
 >-0.01 >-0.01 2.01 0.15 7.54
Currency in USD